Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
The virus that causes cold sores, along with other viral or bacterial infections, may be associated with cognitive problems; a new study from CUMC's Mira Katan and Mitch Elkind.
More symptoms of depression and lower cognitive status are independently associated with a more rapid decline in the ability to handle tasks of everyday living, according to a study by CUMC researchers.
The first evidence that selective activation of the dentate gyrus in the hippocampus can reduce anxiety without affecting learning - important therapeutic implications.